Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing PENG Block in Hip Arthroplasty
NCT07023120Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Jun 2025
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine and dexamethasone in postoperative pain (4 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Time to first rescue opioid analgesia at 24 hours. Started Jun 2025; status: completed.
02
Drugs
ropivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07023120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023120.